Detalles de la búsqueda
1.
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
Br J Haematol
; 204(5): 1762-1770, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38500476
2.
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
Breast Cancer Res Treat
; 169(3): 469-479, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29404806
3.
Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
J Surg Oncol
; 118(1): 221-227, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196538
4.
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).
Support Care Cancer
; 26(2): 643-650, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28921241
5.
Clinicopathologic analysis of a large series of microinvasive breast cancers.
Breast J
; 24(4): 574-579, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29476574
6.
Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
J Genet Couns
; 26(4): 697-715, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27826805
7.
A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.
Br J Haematol
; 174(4): 571-81, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27101934
8.
Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
J Oral Maxillofac Surg
; 74(4): 738-46, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26501428
9.
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020.
JAMA Netw Open
; 7(4): e246235, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38607625
10.
Pathologic Predictors of Treatment Response to Neo-adjuvant Chemotherapy for Invasive Lobular Breast Carcinoma.
Breast J
; 23(5): 607-609, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28328042
11.
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial.
Nat Med
; 28(5): 939-945, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422531
12.
HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Int J Breast Cancer
; 2021: 6684629, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34123431
13.
HER2 Testing: Insights From Pathologists' Perspective on Technically Challenging HER2 FISH Cases.
Appl Immunohistochem Mol Morphol
; 29(9): 635-642, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34282066
14.
Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
Clin Breast Cancer
; 21(1): 47-56, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32739136
15.
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study.
Clin Cancer Res
; 27(11): 3061-3068, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33727258
16.
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Clin Cancer Res
; 26(23): 6132-6140, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998961
17.
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.
NPJ Precis Oncol
; 4: 15, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32596507
18.
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
Clin Breast Cancer
; 19(4): 268-277.e1, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31160171
19.
Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay.
JAMA Oncol
; 4(1): e173470, 2018 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29075751
20.
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin.
Leuk Res
; 44: 25-31, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994848